Position in SNY
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$629,235
+$150,037 QoQ
Shares Held
14,750
+48.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.21%
of 13F equity value
Holder Rank
#301
of 712 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SNY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Persistent Asset Partners Ltd holds $4,144,035 across 7 Drug Manufacturers - General names. SNY ranks #4 (15.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
5,605 | $1,423,501 | |
| 2 | NVO |
Novo Nordisk A S
|
25,600 | $1,227,264 | |
| 3 | AZN |
Astrazeneca PLC
|
4,058 | $769,477 | |
| 4 | SNY |
Sanofi
This page
|
14,750 | $629,235 | |
| 5 | LLY |
ELI LILLY & Co
|
56 | $67,168 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
194 | $24,509 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
50 | $2,881 |
All Filings in SNY
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $629,235 | 14,750 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $479,198 | 9,946 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $360,784 | 7,445 | Shares | Sole | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||